Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04446065` - Previfenon® as Chemoprophylaxis of COVID-19 in Health Workers	Phase 2/Phase 3
Completed	`NCT04419025` - Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease	Phase 2
Not yet recruiting	`NCT04400019` - Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)	Phase 2/Phase 3
Completed	`NCT04463004` - Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation	Phase 2
Completed	`NCT04446429` - Anti-Androgen Treatment for COVID-19	N/A
Completed	`NCT04402957` - LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)	Phase 2
Recruiting	`NCT04441372` - Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection
Recruiting	`NCT04581148` - SARS-CoV2 Antibodies in Pediatric Patients (COVID-19)
Completed	`NCT04530604` - Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS)	Phase 1
Terminated	`NCT04371978` - Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19	Phase 3
Active, not recruiting	`NCT04635605` - Methylene Blue Treatment of COVID-19	Phase 2
Recruiting	`NCT04395599` - Risk of Air Contamination During Visceral Surgery in COVID19 Patients	N/A
Recruiting	`NCT04472585` - Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients	Phase 1/Phase 2
Active, not recruiting	`NCT04411433` - Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19	Phase 3
Completed	`NCT04359706` - Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19
Recruiting	`NCT04395794` - SARS-CoV-2 Disguise Study
Completed	`NCT04386551` - Detection of COVID-19 in Saliva Collection
Recruiting	`NCT04403269` - NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE	Phase 2
Withdrawn	`NCT04379492` - A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19	Phase 2
Completed	`NCT04366934` - Study of the Pathogenesis of Olfactory Disorders in COVID-19

NCT number	NCT04442087
Study type	Interventional
Source	Assistance Publique - Hôpitaux de Paris
Contact
Status	Completed
Phase	N/A
Start date	June 19, 2020
Completion date	April 30, 2021

Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP — FamilyPEDCOVID

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms